mosunetuzumab
roche
['mosunetuzumab', 'lymphoma', 'follicular']
nancy bartlett presents updated results from the phase 2 study on mosunetuzumab in r/r follicular lymphoma. no new safety signals with 28 mo follow up #ash22 
The Lancet Haematology is a world-leading #haematology journal publishing peer-reviewed research and reviews, opinion, and news. #hematology